COMMUNIQUÉS West-GlobeNewswire

Viracta Therapeutics Announces New Employment Inducement Grants

17/05/2024 - 22:05

SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients [...]

NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations

17/05/2024 - 22:04

TORONTO and HAIFA, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company, proudly welcomes [...]

Recludix Pharma Presents Data Demonstrating Oral STAT3 Inhibitors Drive Differentiated Efficacy and Safety in Preclinical Models of Th17 Mediated Skin Inflammation in Oral Plenary Session at SID Annual Meeting

17/05/2024 - 21:00

-- In a preclinical model of psoriasis, the efficacy of oral small molecule REX-7117 was comparable to an anti-IL-17A biologic SAN DIEGO, May 17, 2024 (GLOBE NEWSWIRE) -- Recludix Pharma, a leader in discovery of [...]

Kamari Pharma Announces New Data Presented at the 81st Annual Meeting of the Society for Investigative Dermatology

17/05/2024 - 20:30

Phase 1b clinical trial of KM-001 demonstrated favorable safety profile and high responder rate of 87% in patients with palmoplantar keratoderma and pachyonychia congenita In vitro and in vivo data of KM-001 and KM-023 [...]

Assure & Danam Reschedule Corporate Update Call & Webcast

17/05/2024 - 20:04

DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced today that [...]

More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024

17/05/2024 - 19:45

Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world’s largest pre-college science, technology, engineering and math (STEM) competition. TARRYTOWN, N.Y. and [...]

Better Choice Company Announces First Quarter 2024 Results

17/05/2024 - 18:49

EPS Growth of 28% Year Over Year to $(3.60) Adjusted EBITDA 1 Growth of 27% Year Over Year to $(1.4) Million Adjusted EBITDA Margin 1 of (18)% , a 299 Basis Point Expansion Year Over Year TAMPA, Fla., May 17, 2024 ( [...]

Hepatitis: The silent killer

17/05/2024 - 18:37

Safe vaccination, testing and treatment options widely available JEFFERSON CITY, Mo., May 17, 2024 (GLOBE NEWSWIRE) -- May is Hepatitis Awareness Month, the perfect time for individuals to talk to their health care [...]

Le King Faisal Specialist Hospital & Research Centre lauréat du prix « Tech Impact » VBHC 2024

17/05/2024 - 18:06

RIYAD, Arabie Saoudite, 17 mai 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre, ci-après « KFSH&RC », soit l’hôpital spécialisé et centre de recherche King Faisal, a franchi un cap [...]

Optinose to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

17/05/2024 - 18:00

YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its [...]

AB Science communique un rectificatif sur les comptes consolidés au 31 décembre 2023

17/05/2024 - 17:58

COMMUNIQUE RECTIFICATIF COMMUNIQUE RECTIFICATIF SUR LES COMPTES CONSOLIDES AU 31 DECEMBRE 2023 Paris, 17 mai 2024, 18h AB Science SA (Euronext - FR0010557264 - AB) communique un rectificatif sur les comptes consolidés [...]

BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024

17/05/2024 - 17:15

MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General Meeting (“AGM”) today, May 17, 2024. A total of 87.51 per cent of the share capital was [...]

Novo Nordisk A/S - share repurchase programme

17/05/2024 - 16:20

Bagsværd, Denmark, 17 May 2024 – On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]

IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic Alternatives

17/05/2024 - 16:04

MONTREAL, May 17, 2024 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (the “ Company ” or “ IntelGenx ”) (OCTQB: IGXT; TSX: IGX), a leading drug delivery company focused on the development and manufacturing of [...]

HUTCHMED announces retirement of Chairman, appointment of new Chairman and change of members of board committees

17/05/2024 - 16:00

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ” or the “Company”) (Nasdaq/AIM:HCM, HKEX:13) today announces:- (a) the retirement of Mr Simon To [...]

Assertio to Participate in Benchmark Healthcare Conference on May 21-22

17/05/2024 - 15:15

LAKE FOREST, Ill., May 17, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated [...]

Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety Event

17/05/2024 - 14:30

NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative

17/05/2024 - 14:30

Lee-Sepsick Discussed Company’s FemCerv® Endocervical Tissue Sampler and its Role in Cervical Cancer Diagnosis ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused [...]

Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting

17/05/2024 - 14:00

SEATTLE and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of [...]